Allovir Inc
For the period ended Dec 31, 2023. Filed Mar 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 15, 2024
KLRS$2.42+2.5%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| (in thousands, except share and per share amounts) | 2023 | 2022 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $90,121 | $106,092 |
| Short-term investments | 93,822 | 127,703 |
| Interest receivable | 206 | 157 |
| Prepaid expenses and other current assets | 3,486 | 7,100 |
| Prepaid expenses to related party | — | 2,000 |
| Total current assets | 187,635 | 243,052 |
| Restricted cash | 852 | 852 |
| Other assets | 122 | 612 |
| Property and equipment, net | — | 930 |
| Operating lease right-of-use assets | 2,187 | 31,633 |
| Total assets | $190,796 | $277,079 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $6,761 | $3,004 |
| Accrued expenses | 10,086 | 13,985 |
| Income tax payable | — | 128 |
| Operating lease liability, current | 10,781 | 7,165 |
| Amount due to related party | 739 | 56 |
| Total current liabilities | 28,367 | 24,338 |
| Operating lease liability, long-term | 16,648 | 28,222 |
| Total liabilities | 45,015 | 52,560 |
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value: 10,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively; 0 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | — | — |
| Common stock, $0.0001 par value: 300,000,000 and 150,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively; 114,153,538 and 93,268,069 shares issued at December 31, 2023 and December 31, 2022, respectively; and 114,148,991 and 93,093,243 shares outstanding at December 31, 2023 and December 31, 2022, respectively | 11 | 9 |
| Additional paid-in capital | 802,025 | 690,753 |
| Accumulated other comprehensive loss | (62) | (468) |
| Accumulated deficit | (656,193) | (465,775) |
| Total stockholders’ equity | 145,781 | 224,519 |
| Total liabilities and stockholders’ equity | $190,796 | $277,079 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.